WallStreetZenWallStreetZen

NASDAQ: KURA
Kura Oncology Inc Stock Ownership - Who owns Kura Oncology?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Kura Oncology Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Brian T. PowlChief Commercial Officer2026-05-2110,000$11.00
$110.00kSell
Brian T. PowlChief Commercial Officer2026-05-19339$9.21
$3.12kSell
Kathleen FordChief Operating Officer2026-05-192,257$9.08
$20.48kSell
Teresa Brophy BairChief Legal Officer2026-05-182,256$9.38
$21.16kSell
Troy Edward WilsonPresident and CEO2026-03-236,103$6.15
$37.53kBuy
Thomas MalleyDirector2026-03-1810,000$3.12
$31.20kBuy
Thomas James DoyleSVP Finance Accounting2026-01-272,226$8.46
$18.83kSell
Thomas James DoyleSVP Finance Accounting2026-01-271,114$8.46
$9.43kSell
Thomas James DoyleSVP Finance Accounting2026-01-27695$8.46
$5.88kSell
Thomas James DoyleSVP Finance Accounting2026-01-272,226$8.46
$18.83kSell

1 of 4

KURA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when KURA insiders and whales buy or sell their stock.

KURA Shareholders

What type of owners hold Kura Oncology Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Blackrock Inc10.86%9,637,531$107.27MInstitution
Suvretta Capital Management LLC9.66%8,575,422$95.44MInstitution
Bvf Inc9.51%8,445,769$94.00MInstitution
State Street Corp5.08%4,511,891$50.22MInstitution
Ecor1 Capital Fund Qualified LP4.97%4,408,097$49.06MInsider
Vanguard Capital Management LLC4.26%3,785,685$42.13MInstitution
Armistice Capital LLC4.21%3,736,000$41.58MInstitution
Prosight Management LP3.78%3,356,700$37.36MInstitution
Deep Track Capital LP2.98%2,643,542$29.42MInstitution
Aqr Capital Management LLC2.39%2,124,480$23.65MInstitution

1 of 3

KURA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
KURA90.07%9.93%Net SellingNet Buying
LXRX21.88%78.12%Net BuyingNet Selling
IVA27.10%0.00%
DRTS4.61%0.56%
AKTS52.02%47.98%Net Buying
View Top Biotech Stocks

Kura Oncology Stock Ownership FAQ

Who owns Kura Oncology?

Kura Oncology (NASDAQ: KURA) is owned by 95.04% institutional shareholders, 10.48% Kura Oncology insiders, and 0.00% retail investors. Ecor1 Capital Fund Qualified LP is the largest individual Kura Oncology shareholder, owning 4.41M shares representing 4.97% of the company. Ecor1 Capital Fund Qualified LP's Kura Oncology shares are currently valued at $49.06M.

If you're new to stock investing, here's how to buy Kura Oncology stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.